(IN BRIEF) Roche has announced the acquisition of Poseida Therapeutics, a clinical-stage biopharmaceutical company specializing in off-the-shelf CAR-T cell therapies, for $9.00 per share in cash, ...
Western governments are on edge due to the sudden scarcity of a little-known metal that is critical to both national security and electronics - but one junior miner is now looking to solve that proble ...